IFNG and cancer: Thorsson et al. (2018) identified the ISs, including wound healing (IS1), IFN-γ dominant (IS2), inflammatory (IS3), lymphocyte-depleted (IS4), immunologically quiet (IS5), and TGF-β dominant (IS6) types of cancer.